Vasomotor Symptom Management with Non-Hormonal Options | Webinar
This webinar is targeted at GPs, specialists and allied health workers who are seeking a comprehensive update on non-hormonal therapies for VMS. Although menopausal hormone therapy (MHT) is the most effective option for management of VMS and genitourinary symptoms, some women are unable to use MHT, for personal or health reasons.
Learning outcomes
- Evaluate the contraindications for menopausal hormone therapy
- Describe non-hormonal treatments for vasomotor symptoms
- Design a safe and effective menopause management plan using non-hormonal options for vasomotor symptoms
Dr Sonia Davison, Endocrinologist and AMS Past-President, will take us through evidence-based non-hormonal options for vasomotor symptoms, including a new therapy using a neurokinin 3 (NK3) receptor antagonist. AMS Past-President Dr Sylvia Rosevear will chair the meeting and there will be plenty of time for questions.
Sylvia is the current AMS President and a New Zealand Obstetrician and Gynaecologist. She graduated from the University of Auckland and completed her obstetrics and gynaecology training at the National Women’s Hospital. Sylvia completed an MD at Oxford and has worked in private practice in New Zealand since 1993. She is interested in the endocrinology of the menopause and the maintenance and optimisation of middle-aged health, rather than just prevention of pathology.
Sonia is an Endocrinologist with a special interest in Women’s Health. She is a Clinical Fellow at Jean Hailes for Women’s Health and has worked at the Women’s Health Research Program, Monash University. Sonia is in private practice at the Melbourne Endocrine Clinic, Malvern and at Jean Hailes for Women’s Health. Her PhD and postdoctoral research examined sex steroid physiology in women, including measurement of androgens and their relationships with age, mood, sexual function and cognition. Sonia is Past President of the Australasian Menopause Society and former editor of its newsletter, ‘Changes’
